• Science & Technology

Artificial intelligence reveals prostate cancer is not just one disease

Research published in Cell Genomics today has shown that prostate cancer, which affects one in six men in the UK in their lifetime, includes two different subtypes of the disease, also known as evotypes. Research published in Cell Genomics today has shown that prostate cancer, which affects one in six men in the UK in their lifetime, includes two different subtypes of the disease, also known as evotypes.

29 February 2024

• For Researchers

Understanding metastasis in the light of evolution

Getting to grips with metastasis means understanding the evolutionary mechanisms behind this complex biology, says Dr Simone Zaccaria... Getting to grips with metastasis means understanding the evolutionary mechanisms behind this complex biology, says Dr Simone Zaccaria...

27 February 2024

• Policy & Insight
• Science & Technology

Why the next government needs to support clinical research - for our health and the NHS

Deciding to support clinical research is one of the most consequential choices a government can make. Our latest survey of the clinical research workforce uncovers what's needed to bring more potentially lifesaving treatments to patients, and to improve the NHS. Deciding to support clinical research is one of the most consequential choices a government can make. Our latest survey of the clinical research workforce uncovers what's needed to bring more potentially lifesaving treatments to patients, and to improve the NHS.

12 February 2024

• Health & Medicine
• Science & Technology

Oesophageal cancer awareness month: 4 articles on the latest in prevention and treatment

For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.   For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.  

9 February 2024

• Science & Technology

The secret in cancer cells that can make immunotherapy more effective

Our researchers have found mutations that make cancers much more likely to respond to immunotherapy. It's a chance to make breakthrough treatments work for many more people. Our researchers have found mutations that make cancers much more likely to respond to immunotherapy. It's a chance to make breakthrough treatments work for many more people.

31 January 2024

• Science & Technology

Cellular scavengers: How breast cancers ‘eat’ their support systems when they need nutrients

New research we've funded has found that breast cancers can break down molecules in their support system to use as a source of nutrients. As healthy cells can't use this chemical pathway to make food, it could lead to a new targeted breast cancer treatment. New research we've funded has found that breast cancers can break down molecules in their support system to use as a source of nutrients. As healthy cells can't use this chemical pathway to make food, it could lead to a new targeted breast cancer treatment.

17 January 2024

• Health & Medicine
• Science & Technology

Can a capsule sponge change how we diagnose oesophageal cancer?

Our BEST4 trial will show if a capsule sponge test can be used to monitor people at high risk of oesophageal cancer. It could give the NHS a quick and simple new screening test for oesophageal cancer and save thousands of lives every year.  Our BEST4 trial will show if a capsule sponge test can be used to monitor people at high risk of oesophageal cancer. It could give the NHS a quick and simple new screening test for oesophageal cancer and save thousands of lives every year. 

11 January 2024

• Health & Medicine

New neuroblastoma treatment combo helps more children with relapsed disease

We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.   We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.  

10 January 2024

• Science & Technology
• Health & Medicine

2023 roundup: 5 of our most important cancer research stories of the year

2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023. 2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023.

18 December 2023

• For Researchers

MOv18 - opening a new front for immunotherapy

Follow Sophia Karagiannis and James Spicer on an immunological adventure as they develop a ground-breaking new class of drug... Follow Sophia Karagiannis and James Spicer on an immunological adventure as they develop a ground-breaking new class of drug...

12 December 2023

• Policy & Insight

What the autumn statement means for cancer research

Here are our initial thoughts on what the 2023 autumn statement means for the UK's cancer research environment.   Here are our initial thoughts on what the 2023 autumn statement means for the UK's cancer research environment.  

22 November 2023